Rachel Streiff
Product Support Specialist @Athelas
Signup · Get unlimited contacts
WORK HISTORY
Product Support Specialist @Athelas
US
Ensure every suffering patient has unrestricted access to Clozaril® (clozapine), the “Gold Standard” in treating psychosis disorders and preventing suicide.
EDUCATION
University of Arizona
Bachelor of Science, Chemical Engineering, Biomedical Option
SKILLS
ABOUT RACHEL STREIFF
Clozaril® (clozapine) is the only medication in history to receive an FDA-approved indication to prevent suicide. Clozaril® is the “Gold Standard” in treating psychosis disorders, with 50 years of superior efficacy and proven reduction in all causes of mortality compared to all other antipsychotic medications.Yet, thousands of acutely ill psychiatric patients in the US die every year waiting to access to this lifesaving medication. Frequent hematological monitoring is an insurmountable barrier for most eligible patients. The FDA-approved Athelas Home® finger stick ANC device is the most important innovation for the treatment of Serious Mental Illness (SMI) in the past decade. This cost-effective solution saves lives, reduces treatment costs, and prevents hospitalization, violence, disability and incarceration by improving and simplifying patient care.My life’s mission is to ensure every suffering patient has access to this vital medication and supportive technology. The sickest among us deserve the Gold Standard treatment.I am honored to be a member of the Athelas + Commure team.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.